- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jan 18, 2025
Product Development
2025 catalysts: New modality showdowns
Genetic therapies compete in the same indications, as degraders come of age
BioCentury | Jul 5, 2010
Emerging Company Profile
ProNoxis: Promoting ROS
ProNoxis hopes reactive oxygen species provide a benefit in rheumatoid arthritis
Items per page:
1 - 4 of 4